** Klausberger, M; Kienzl, NF; Stadlmayr, G; Grünwald-Gruber, C; Laurent, E; Stadlbauer, K; Stracke, F; Vierlinger, K; Hofner, M; Manhart, G; Gerner, W; Grebien, F; Weinhäusel, A; Mach, L; Wozniak-Knopp, G; Designed SARS-CoV-2 receptor binding domain variants form stable monomers..
** Zhu, R; Canena, D; Sikora, M; Klausberger, M; Seferovic, H; Mehdipour, AR; Hain, L; Laurent, E; Monteil, V; Wirnsberger, G; Wieneke, R; Tampé, R; Kienzl, NF; Mach, L; Mirazimi, A; Oh, YJ; Penninger, JM; Hummer, G; Hinterdorfer, P; Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level..
** Capraz, T; Kienzl, NF; Laurent, E; Perthold, JW; Föderl-Höbenreich, E; Grünwald-Gruber, C; Maresch, D; Monteil, V; Niederhöfer, J; Wirnsberger, G; Mirazimi, A; Zatloukal, K; Mach, L; Penninger, JM; Oostenbrink, C; Stadlmann, J; Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor..
** Castilho, A; Schwestka, J; Kienzl, NF; Vavra, U; Grünwald-Gruber, C; Izadi, S; Hiremath, C; Niederhöfer, J; Laurent, E; Monteil, V; Mirazimi, A; Wirnsberger, G; Stadlmann, J; Stöger, E; Mach, L; Strasser, R; Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana..
** Paumann-Page, M; Kienzl, NF; Motwani, J; Bathish, B; Paton, LN; Magon, NJ; Sevcnikar, B; Furtmuller, PG; Traxlmayr, MW; Obinger, C; Eccles, MR; Winterbourn, CC Peroxidasin protein expression and enzymatic activity in metastatic melanoma cell lines are associated with invasive potential.
** Shin, YJ; Konig-Beihammer, J; Vavra, U; Schwestka, J; Kienzl, NF; Klausberger, M; Laurent, E; Grunwald-Gruber, C; Vierlinger, K; Hofner, M; Margolin, E; Weinhausel, A; Stoger, E; Mach, L; Strasser, R N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants.